Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Observe Medical ASA: Agreement reached with Convatec to defer payments by 12 months

Oslo, 19 November, 2024 – Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company" or "Observe Medical") on 12 November 2024, in which it inter alia was stated that the Company is in dialogue with strategic and financial partners to evaluate options to further strengthen its working capital situation. The Company has today, through its subsidiary Observe Medical AS, reached an agreement with Convatec/Unomedical to defer all outstanding payments of consideration pursuant to the asset transfer agreement with Convatec/Unomedical for the

BioStock: Lipum presents promising phase I data at ACR 2024

Lipum will present positive data from the phase I study of its drug candidate SOL-116 at the American College of Rheumatology (ACR) Annual Meeting 2024, a leading global conference in rheumatology. The interim results confirm that SOL-116 demonstrates a favourable safety profile and pharmacokinetics in line with expectations. The study approaches its conclusion, and Lipum plans to share the final report in the first quarter of 2025.Read the full article at biostock.se : https://www.biostock.se/en/2024/11/lipum-presents-promising-phase-i-data-at-acr-2024/

Capital Markets Day: A solid foundation for growth and updated financial targets

DNB is hosting the Group's Capital Markets Day in London today. Our financial targets for 2025–2027 are as follows: · Return on equity (ROE) above 14% (from above 13%) · Cost/income (C/I) ratio below 40% (no change) · Dividend payout ratio of over 50% and an ambition to increase the nominal dividends per share per year (no change) · Common equity Tier 1 (CET1) capital ratio above 16.7% (no change) Furthermore, our growth ambitions over time are as follows:  · Annual growth in loan volumes: 3-4% (no change)  · Annual growth in commission and fee income: above 9% (

Circio announces circVec LNP-delivery collaboration with Certest progressing to in vivo testing

· Certest Biotec, S.L. and Circio are collaborating to create and test circVec DNA-LNP formulations for potential therapeutic applications · Certest´s proprietary ionizable lipids and their optimized LNP formulations have shown impressive delivery specificity to several tissues of interest to Circio, including lung, liver and spleen · Technical formulation and in vitro analysis of circVec-LNP formulations by Certest have been successful, and the collaboration will now progress to in vivo delivery testingOslo, Norway 19 November 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology

Cinis Fertilizer’s nomination committee ahead of the 2025 Annual General Meeting

The composition of the nomination committee in Cinis Fertilizer AB is hereby announced ahead of the 2025 Annual General Meeting.The nomination committee consists of the following members appointed by the largest shareholders, based on voting rights, as per 30 September 2024, as well as the Chairman of the Board: · Frederik Nilner, appointed by shareholder Jakob Liedberg(36.4% of votes and capital as of 30 September 2024) · Thomas Ranje, representing himself(15.3% of votes and capital as of 30 September 2024) · Morgan Sadarangani, appointed by shareholder Molindo Energy AB(3.

#24-116 Unit issue in Adverty AB

With the support of the authorization from the extra general meeting on November 13, 2024, the board of Adverty AB (“the Company”) has decided on a unit issue with preferential rights for the Company’s existing shareholders.The last day of trading in the Company’s shares including the right to receive unit rights is November 20, 2024. The first day of trading in the Company’s shares excluding the right to receive unit rights is November 21, 2024. The record date is November 22, 2024.The shareholders of the Company will receive one (1) unit right for each share held per the record date.

Ahlsell acquires KS Værktøj A/S

Ahlsell Denmark, through its subsidiary KJV A/S, has signed an agreement to acquire all shares in KS Værktøj A/S. The company will henceforth become part of the industrial specialist KJV A/S.KS Værktøj A/S offers a broad assortment in; tools, technical articles and workwear and is known for providing a high level of service to the industry. The company has 15 employees and a turnover of 31 MDKK (2023). KS Værktøj A/S operate with stores in Maribo and Rødbyhavn on Lolland-Falster. Through this acquisition, Ahlsell continues to strengthen its offering to industrial customers in these regions.

Scania opens up access to digital ecosystem to diverse and mixed-brand fleets

Complete Fleet concept is Scania’s response to the realities of today’s complex and multi-layered haulage industry. By integrating their entire fleets and trailers into the full range of Scania’s digital services, hauliers can connect not just their Scania vehicles but those of other truck manufacturers, too.Today, Scania introduces its Complete Fleet concept for digital services. Regardless of vehicle brand or type, all of the vehicles and trailers in a customer’s fleet can now have the same comprehensive access to Scania’s growing range of digital services, such as positioning, tachograph,

Inside information: Delay in reaching targeted process metrics required for moving to pre-engineering of the 20kt factory investment planned by Suzano

SPINNOVA PLC, COMPANY RELEASE, INSIDE INFORMATION 19 NOVEMBER 2024 at 11:40 a.m. EET   Inside information: Delay in reaching targeted process metrics required for moving to pre-engineering of the 20kt factory investment planned by Suzano   In March 2024, Spinnova Plc and Suzano S.A. signed a Letter of Intent (LOI) regarding a potential new production facility for wood-based SPINNOVA® fibre. It was expected that the pre-engineering phase of the new facility would commence in the second half of 2024. Reaching the targeted process metrics required for the project to move to the pre-

ASETEK A/S – Major shareholding announcement

Asetek A/S (the "Company") has been informed that Nordic Compound Invest A/S (company reg. (cvr.) no. 41381205) on 12 November 2024 held 8,040,050 Asetek shares and thereby more than 5% of the share capital and voting rights of the Company. For further information, please contact: Per Anders Nyman, Head of Investor Relations Mobile: +45 2566 6869 E-mail: investor.relations@asetek.com About Asetek Asetek (ASTK), a global leader in mechatronic innovation, is a Danish garage-to-stock-exchange success story. Founded in 2000, Asetek established its innovative position as the

Fiskars Corporation to start to acquire the company’s own shares

Fiskars CorporationStock Exchange ReleaseNovember 19, 2024 at 11:15 a.m. EET Fiskars Corporation to start to acquire the company’s own sharesThe Board of Directors of Fiskars Corporation has decided to commence acquiring the company’s own shares on the basis of the authorization given by the Annual General Meeting held on March 13, 2024. The maximum number of shares to be acquired is 200,000, corresponding to approximately 0.2% of the total number of shares. The shares shall be acquired through public trading on the Nasdaq Helsinki exchange at the market price prevailing at the

Pandox Hotel Market Day 2024: A New Dawn - The European Hotel Market in a Changing World

Pandox is holding its annual Hotel Market Day today. The theme is "A New Dawn - The European Hotel Market in a Changing World", focusing on how geopolitics, economic shifts and changing consumer behaviour affect the European hotel industry.  "At this year's Hotel Market Day, we will deepen the analysis of the geopolitical shifts that are taking place in the world and how they affect the hotel industry in Europe. I look forward to a fun and inspiring day with good speakers, interesting discussions and new insights," says Liia Nõu, CEO of Pandox.   This year's Hotel Market Day is

Quay 16 – innovative construction project in Lilla Bommen in Gothenburg

On behalf of Vasakronan, the Eleda company Mark & Energibyggarna is carrying out ground and foundation work in the Quay 16 project. With a focus on sustainability and innovation, the foundation is now laid for a modern property with a high environmental profile.Concrete piles and aggregates from the dismantled property Kromet, which previously stood at the quayside in Lilla Bommen, will be repurposed in Quay 16. A solution that both reduces climate impact and contributes to sustainable construction. Quay 16 is located on the quayside at the Hisingsbron abutment near the Göta River, which

Alisa Bank Plc - Managers' Transactions - WRCC Invest Oy

ALISA BANK PLC MANAGER TRANSACTIONS 19.11.2024 AT 10.50 EETPerson subject to the notification requirementName: WRCC Invest Oy Position: Member of the Board/Deputy member(X) Legal person (1): Person Discharging Managerial Responsibilities In IssuerName: Tero WeckrothPosition: Member of the Board Issuer: Alisa Pankki OyjLEI: 743700VK1NB8HRGTQH74Notification type: INITIAL NOTIFICATIONReference number: 85221/4/4 Transaction date: 2024-11-18-24Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000170915Nature of transaction: ACQUISITION

Alisa Pankki Plc - Managers' Transactions - SH Ventures Oy

ALISA BANK PLC MANAGER TRANSACTIONS 19.11.2024 AT 10.40 EETPerson subject to the notification requirementName: SH Ventures OyPosition: Member of the Board/Deputy member(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Sami HonkonenPosition: Member of the Board Issuer: Alisa Pankki OyjLEI: 743700VK1NB8HRGTQH74Notification type: INITIAL NOTIFICATIONReference number: 85045/6/4 Transaction date: 2024-11-15Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000170915Nature of transaction: ACQUISITION  Transaction

Anora sells its Swedish Snälleröds schnapps brand to Saturnus

Anora, the leading Nordic wine and spirits brand house, has completed the sale of its Swedish schnapps brand Snälleröds to the Malmö-based beverage company Saturnus AB. As part of the agreement, Saturnus will take over the production, distribution, and sales of Snälleröds products effective from 18 November 2024. This allows Anora to further focus on its core brands and streamline its portfolio.The divestment includes the Snälleröds schnapps brand and its two products as well as the production equipment from the Snälleröds micro-distillery located in Ljungbyhed, Sweden. The sale is aligned

Alisa Bank Plc - Managers' Transactions - Weckroth

ALISA BANK PLC MANAGER TRANSACTIONS 19.11.2024 AT 10.30 EETPerson subject to the notification requirementName: Tero WeckrothPosition: Member of the Board/Deputy memberIssuer: Alisa Pankki OyjLEI: 743700VK1NB8HRGTQH74 Notification type: INITIAL NOTIFICATIONReference number: 84891/5/4 Transaction date: 2024-11-14-24Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000170915Nature of transaction: ACQUISITION  Transaction details(1): Volume: 25000 Unit Price: 0.1704 EUR  (2): Volume: 25000 Unit Price: 0.18 EUR Aggregated transactions (2): Volume:

DanCann Pharma A/S: The Danish Government Proposes Permanent Scheme for Prescription-Based Medicinal Cannabis for Danish Patients

COPENHAGEN, Denmark, 19 November 2024 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, hereby announces that the Danish government has expressed its intention to make the Pilot Programme for prescription-based medicinal cannabis permanent. This proposal will be presented today by the Minister of the Interior and Health, Sophie Løhde, during negotiations with the political parties supporting the initiative. The decision is based on a recent evaluation that highlights a significant increase in the number of prescriptions filled,

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 250 – 19 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com Isabella Zaugg Hansen, Investor Relations Manager, tel.: +45 27 62 90 96, e-mail: izh@norden.com

Alisa Bank Plc - Managers' Transactions - WRCC Invest Oy

ALISA BANK PLC MANAGER TRANSACTIONS 19.11.2024 AT 10.20 EETPerson subject to the notification requirementName: WRCC Invest Oy Position: Member of the Board/Deputy member(X) Legal person (1): Person Discharging Managerial Responsibilities In IssuerName: Tero WeckrothPosition: Member of the Board Issuer: Alisa Pankki OyjLEI: 743700VK1NB8HRGTQH74Notification type: INITIAL NOTIFICATIONReference number: 85039/5/4  Transaction date: 2024-11-15-24Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000170915Nature of transaction: ACQUISITION

New integration changes the game for emission reporting

SmartCraft is launching an integration between Tellus and Coredination today, two innovative platforms within its ecosystem. This integration is designed to streamline environmental reporting, helping transport companies comply with the latest regulations and set new standards for efficiency and transparency.   The integration enables real-time emission data transfer from Tellus directly to Coredination a mobile workflow platform tailored for field workers. By automating the reporting process, this integration makes it easier for transport companies to meet strict

Recipharm’s full range Oral Solid Dosage (OSD) capabilities meet growing industry demands

· Full range OSD development and manufacturing capabilities from orphan drugs to blockbusters · High potency manufacturing capabilities expansion · Introduction of ReciPredict platform to accelerate product development and de-risk tech transfer · API capabilities from route scouting to large scale synthesisRecipharm, a leading global contract development and manufacturing organisation (CDMO), has significantly enhanced its capabilities in the development and production of orally delivered drug products. With a strong legacy in API development, product development and manufacturing

There are no items matching the current filter
There are no more items matching the current filter
Back to top